AC8
Auscann Group Holdings Ltd
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
11
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
AusCann Group Holdings Ltd. engages in development, production, and distribution of cannabinoid-based medicines within Australia and internationally. The company is headquartered in Perth, Western Australia. Its products include Neuvis, CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways. MicroMAX is an encapsulation technology for use in the field of animal therapeutics. Its subsidiaries include AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited.
📈 Performance
Price History
-84.62%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.04
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AC8
11
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in AC8
673 days
AC8 investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
15%
50k - 100k
62%
Less than 50k
23%
👶 Age of investors
18 - 25
9%
26 - 34
36%
35 - 90
55%
🙋 Legal gender of investors
Female
73%
Male
27%
Pearlers who invest in AC8 also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.
📊 Share price
$0.17 AUD
IMPQ.AX was created on 2021-09-29 by eInvest. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to deliver long-term capital growth predominately through investments in Australian and New Zealand listed smaller and mid-cap companies that are Better Future Investments.
📊 Share price
$4.98 AUD
NULL AUSTRALIA
NULL OTHER
NULL NEW ZEALAND
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
NULL ACTIVE
NULL IMPACT
Althea Group Holdings Ltd. is an investment company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-09-21. The firm services these sectors via two business units: Althea and Peak Processing Solutions. Althea is its pharmaceutical business that offers a range of cannabis-based medicines which are made available to patients via prescription. Althea offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. Peak Processing Solutions is its recreational cannabis business, which produces legal cannabis products purchased by adult consumers in retail stores. Peak Processing Solutions provides formulation and mass-manufacturing of recreational cannabis products, including beverages, concentrates, topicals and others. The firm operates in regulated and legal cannabis markets across Europe, North America, Australia, and Africa.
📊 Share price
$0.05 AUD
Want more shares? Try these...
A-Cap Energy Ltd. engages in the exploration of minerals. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-05-19. The firm is focused on the development of new energy projects including its flagship Letlhakane Uranium Project in Botswana. The company is focused on the exploration and acquisition of nickel cobalt projects to supply cathode materials to the global electric vehicle battery industry and developing the base load Letlhakane uranium energy resource project in Botswana. Its projects include Letlhakane Uranium Project and Wilconi Nickel Cobalt Project. The Letlhakane Uranium Project lies adjacent to Botswana’s main North-South infrastructure corridor, which includes a sealed all-weather highway, railway line and the national power grid. The Wilconi Nickel Cobalt Project is situated approximately 700 kilometers from Perth and has associated infrastructure in the vicinity. The township of Wiluna lies immediately east of the project. The project is the northern part of the Agnew-Wiluna greenstone belt.
📊 Share price
